![\"\"](\"https:\/\/prizrenpost.com\/al\/wp-content\/uploads\/2021\/01\/astrazeneca.jpg\")
<\/p>\n<\/p>\n
LOND\u00cbR – M\u00eb 30 dhjetor, 2020, Britania u b\u00eb shteti i par\u00eb q\u00eb miratoi p\u00ebr p\u00ebrdorim vaksin\u00ebn kund\u00ebr koronavirusit t\u00eb kompanis\u00eb AstraZeneca dhe Universitetit t\u00eb Oxford-it \u2013 duke shtuar edhe nj\u00eb arm\u00eb n\u00eb arsenalin e k\u00ebtij vendi, n\u00eb luft\u00ebn kund\u00ebr pandemis\u00eb, shkruan agjencia e lajmeve Reuters.<\/strong><\/p>\n Megjithat\u00eb, shkenc\u00ebtar\u00ebt \u2013 si dhe rregullator\u00ebt e barnave n\u00eb Evrop\u00eb \u2013 jan\u00eb skeptik\u00eb, p\u00ebr shkak t\u00eb konfuzionit t\u00eb shkaktuar nga rezultatet e studimit t\u00eb vaksin\u00ebs t\u00eb prodhuar nga AstraZeneca q\u00eb b\u00ebri q\u00eb ekspert\u00ebt t\u00eb kishin dyshime mbi t\u00eb dh\u00ebnat e publikuara.<\/p>\n Sa \u00ebsht\u00eb efektive vaksina e AstraZeneca\/Oxford?<\/p>\n Efikasiteti i vaksin\u00ebs AstraZeneca\/Oxford n\u00eb parandalimin e infeksioneve simptomatike ishte 70.4 p\u00ebr qind, krahasuar me 95 p\u00ebr qind efikasitet q\u00eb \u00ebsht\u00eb th\u00ebn\u00eb se ka doza e vaksin\u00ebs s\u00eb Pfizer\/BioNTech dhe vaksinave t\u00eb tjera t\u00eb miratuara p\u00ebr p\u00ebrdorim n\u00eb Britani.<\/p>\n Pas miratimit, autoritetet n\u00eb Britani than\u00eb se nj\u00eb doz\u00eb e vaksin\u00ebs s\u00eb AstraZenecas ishte 52.7 p\u00ebr qind efektive, edhe pse k\u00ebshilluesi mjek\u00ebsor i Britanis\u00eb tha se nj\u00eb doz\u00eb e vaksin\u00ebs s\u00eb k\u00ebsaj kompanie, pas tre jav\u00ebsh duhet t\u00eb tregoj\u00eb 70 p\u00ebr qind efektivitet.<\/p>\n Rregullatori britanik rekomandon q\u00eb doza e dyt\u00eb t\u00eb merret kat\u00ebr deri n\u00eb 12 jav\u00eb pas doz\u00ebs s\u00eb par\u00eb sepse rreth 80 p\u00ebr qind efektivitet i vaksin\u00ebs u arrit me nj\u00eb diferenc\u00eb kohore prej tre muajsh nga doza e par\u00eb te e dyta, tha nj\u00eb zyrtar q\u00eb ka qen\u00eb i p\u00ebrfshir\u00eb n\u00eb miratimin e vaksin\u00ebs.<\/p>\n Vaksina \u00ebsht\u00eb miratuar nga Agjencia rregullative e Barnave dhe Produkteve Mjek\u00ebsore e Mbret\u00ebris\u00eb s\u00eb Bashkuar.<\/p>\n Konfuzioni rreth efikasitetit t\u00eb vaksin\u00ebs erdhi pasi n\u00eb fund t\u00eb n\u00ebntorit t\u00eb vitit t\u00eb kaluar, kompania farmaceutike AstraZeneca pranoi se disa njer\u00ebz gjat\u00eb provave klinike, aksidentalisht kishin marr\u00eb doza t\u00eb ndryshme.<\/p>\n Ata q\u00eb mor\u00ebn fillimisht gjysm\u00eb doz\u00eb t\u00eb vaksin\u00ebs, pasuar nga nj\u00eb doz\u00eb e plot\u00eb, kishin treguar se vaksina kishte efekt t\u00eb mbrojtjes deri n\u00eb 90 p\u00ebr qind, tha fillimisht kjo kompani. Nd\u00ebrkaq, personat q\u00eb kishin marr\u00eb dy doza t\u00eb plota t\u00eb vaksin\u00ebs, ajo kishte ofruar vet\u00ebm 62 p\u00ebr qind mbrojtje nga s\u00ebmundja COVID-19, q\u00eb e shkakton koronavirusi.<\/p>\n Megjithat\u00eb, Agjencia britanike e Barnave tha se rezultatet e personave q\u00eb mor\u00ebn pjes\u00eb n\u00eb studim dhe q\u00eb iu administrua vet\u00ebm gjysm\u00eb doz\u00eb e vaksin\u00ebs, nuk u mor\u00ebn parasysh gjat\u00eb analizave.<\/p>\n \u201cE gjith\u00eb kjo \u00ebsht\u00eb edhe m\u00eb konfuze sepse realisht jan\u00eb b\u00ebr\u00eb gabime\u201d, tha p\u00ebr Retuers nj\u00eb zyrtar nga Agjencia Evropiane e Barnave.<\/p>\n \u201cGabime q\u00eb rezultuan n\u00eb t\u00eb dh\u00ebnat klinike jan\u00eb m\u00eb komplekse p\u00ebr t\u2019u interpretuar sesa ato t\u00eb (kompanive) Moderna dhe Pfizer. Dhe mbi t\u00eb gjitha, efikasiteti (i vaksin\u00ebs s\u00eb AstraZenecas) \u00ebsht\u00eb m\u00eb i ul\u00ebt\u201d, shtoi ky zyrtar.<\/p>\n Cilat jan\u00eb dallimet e tjera?<\/p>\n Teknologjia, \u00e7mimi dhe ruajtja.<\/p>\n Vaksina e AstraZenecas \u00ebsht\u00eb \u201cvaksin\u00eb e vektorit viral\u201d, ku nj\u00eb virus i dizajnuar p\u00ebr shimpanzet\u00eb q\u00eb t\u00eb marrin gripin e zakonsh\u00ebm, i jep udh\u00ebzime qelizave t\u00eb njer\u00ebzve t\u00eb q\u00eb b\u00ebjn\u00eb q\u00eb proteinat t\u00eb dalin nga sip\u00ebrfaqja e koronavirusit t\u00eb ri.<\/p>\n Vaksinat e prodhuara nga Pfizer\/BioNTech dhe Moderna p\u00ebrdorin nj\u00eb teknologji t\u00eb re, mRNA, q\u00eb b\u00ebn q\u00eb acidi ribonukleik (ARN) t\u00eb futet brenda pik\u00ebzave t\u00eb yndyr\u00ebs dhe instrukton qelizat q\u00eb t\u00eb krijojn\u00eb proteina.<\/p>\n AstraZeneca ka th\u00ebn\u00eb se dozat e vaksin\u00ebs do t\u00eb kushtojn\u00eb vet\u00ebm disa dollar\u00eb dhe do t\u00eb shiten pa p\u00ebrfitim, nd\u00ebrkaq nj\u00eb doz\u00eb e vaksin\u00ebs s\u00eb Pfizerit kushton 18.40 dollar\u00eb -19.50 dollar\u00eb .<\/p>\n Edhe vaksina e Modernas q\u00eb \u00ebsht\u00eb krijuar me teknologjin\u00eb mRNA \u00ebsht\u00eb miratuar p\u00ebr p\u00ebrdorim n\u00eb shtetet e Bashkuara dhe kushton 37 dollar\u00eb.<\/p>\n Dozat e vaksin\u00ebs s\u00eb AstraZenecas nuk k\u00ebrkojn\u00eb q\u00eb t\u00eb ruhen n\u00eb temperatura shum\u00eb t\u00eb ftohta deri n\u00eb -70 grad\u00eb Celsius, ashtu si\u00e7 k\u00ebrkohen t\u00eb ruhen vaksinat e prodhuara me teknologjin\u00eb mRNA nga kompania amerikane Pfizer dhe partneri i tij gjerman BioNTech.<\/p>\n AstraZeneca tashm\u00eb ka prodhuar miliona doza t\u00eb vaksin\u00ebs. Ato mund t\u00eb ruhen n\u00eb frigorifer\u00eb standard deri n\u00eb gjasht\u00eb muaj.<\/p>\n Kjo vaksin\u00eb po ashtu \u00ebsht\u00eb m\u00eb e lir\u00eb p\u00ebr t\u2019u prodhuar, duke rritur shpresat p\u00ebr vendet n\u00eb zhvillim q\u00eb ende nuk kan\u00eb arritur t\u00eb sigurojn\u00eb vaksinat.<\/p>\n A do t\u00eb miratohet vaksina edhe n\u00eb shtetet e tjera? SHBA-ja ka miratuar edhe vaksin\u00ebn e Modernas, q\u00eb \u00ebsht\u00eb krijuar po ashtu me teknologjin\u00eb mRNA. Vaksinat me k\u00ebt\u00eb teknologji p\u00ebrpunojn\u00eb kodin gjenetik t\u00eb virusit.<\/p>\n Vendimi i Britanis\u00eb p\u00ebr t\u00eb miratuar vaksin\u00ebn e AstraZenecas ka si prioritet vaksinimin e m\u00eb shum\u00eb personave sa m\u00eb shpejt q\u00eb t\u00eb jet\u00eb e mundur, p\u00ebrpara se t\u00eb gjitha p\u00ebrgjigjet lidhur me efikasitetin t\u00eb jen\u00eb n\u00eb dispozicion.<\/p>\n \u201cMiratimi emergjent n\u00ebnkupton marrjen e rreziqeve t\u00eb nj\u00eb efikasiteti m\u00eb t\u00eb ul\u00ebt apo m\u00eb t\u00eb shkurt\u00ebr sesa q\u00eb mund t\u00eb arrihet me vaksinat me teknologjin\u00eb mRNA\u201d, thot\u00eb Claire-Anne Siegrist, q\u00eb drejton departamentin e vaksinologjis\u00eb dhe imunologjis\u00eb n\u00eb Spitalin Universitar t\u00eb Gjenev\u00ebs.<\/p>\n P\u00ebrderisa zyrtar\u00ebt e Agjencis\u00eb Evropiane t\u00eb Barnave than\u00eb se ka pak gjasa q\u00eb vaksina e AstraZenecas t\u00eb miratohet deri n\u00eb fund t\u00eb janarit, nj\u00eb zyrtar gjerman p\u00ebr vaksina tha se pret q\u00eb Evropa t\u00eb \u201cmarr\u00eb vendim t\u00eb shpejt\u201d lidhur me miratimin e k\u00ebsaj vaksine.<\/p>\n Edhe India e ka miratuar m\u00eb 2 janar vaksin\u00ebn e AstraZeneca\/Oxford.<\/p>\n Kush do ta marr\u00eb vaksin\u00ebn?<\/p>\n Sh\u00ebrbimi Komb\u00ebtar i Sh\u00ebndetit n\u00eb Angli nuk do t\u2019i jap\u00eb mund\u00ebsi njer\u00ebzve q\u00eb ta zgjedhin vaksin\u00ebn q\u00eb do t\u2019iu administrohet kund\u00ebr koronavirusit.<\/p>\n Por, teksa disa vaksina tashm\u00eb jan\u00eb t\u00eb qasshme, shtetet duhet t\u00eb vendosin se kush duhet ta marr\u00eb cil\u00ebn vaksin\u00eb, pasi q\u00eb disa njer\u00ebz mund t\u00eb preferojn\u00eb q\u00eb t\u2019iu administrohet vaksina q\u00eb ka m\u00eb shum\u00eb efikasitet.<\/p>\n Ekspert\u00ebt thon\u00eb se dallimet n\u00eb nivelin e efikasitetit jan\u00eb t\u00eb r\u00ebnd\u00ebsishme, gj\u00eb q\u00eb sipas tyre, do t\u00eb b\u00ebj\u00eb q\u00eb zgjedhja se cila vaksin\u00eb t\u00eb p\u00ebrdoret t\u00eb jet\u00eb e v\u00ebshtir\u00eb.<\/p>\n \u201cN\u00eb shtetet ku vaksinat edhe me teknologjin\u00eb mRNA dhe t\u00eb AstraZenecas do t\u00eb jen\u00eb t\u00eb qasshme, kush do t\u00eb vendos\u00eb q\u00eb nj\u00eb grupi shoq\u00ebror t\u2019i administrohet vaksina m\u00eb pak efektive?\u201d, shprehet Sigrist.<\/p>\n Thomas Mertenes, udh\u00ebheq\u00ebs i Komitetit t\u00eb P\u00ebrhersh\u00ebm t\u00eb Vaksinave (STIKO), panel n\u00eb Gjermani q\u00eb mbik\u00ebqyr\u00eb p\u00ebrdorimin e vaksinave, i tha Reuters se ky institucion planifikon q\u00eb ta shqyrtoj\u00eb k\u00ebt\u00eb \u00e7\u00ebshtje \u201cn\u00eb nj\u00eb t\u00eb ardhme t\u00eb af\u00ebrt\u201d, pasi shpresojn\u00eb q\u00eb t\u00eb hartojn\u00eb nj\u00eb strategji q\u00eb do t\u00eb ket\u00eb ndikim m\u00eb t\u00eb madh me furnizime t\u00eb kufizuara t\u00eb vaksinave.<\/p>\n Megjithat\u00eb, disa ekspert\u00eb thon\u00eb se zgjedhja se cil\u00ebn vaksin\u00eb ta p\u00ebrdorin \u00ebsht\u00eb nj\u00eb luks q\u00eb shtetet nuk mund ta p\u00ebrballojn\u00eb.<\/p>\n \u201cN\u00eb k\u00ebto momente, ne nuk kemi sasi t\u00eb mjaftueshme t\u00eb vaksinave p\u00ebr t\u00eb gjith\u00eb personat q\u00eb kan\u00eb nevoj\u00eb p\u00ebr to\u201d, tha Thomas Klimkait, profesor n\u00eb Uniersitetin e Bazelit, nj\u00ebher\u00ebsh hulumtues q\u00eb po punon n\u00eb nj\u00eb projekt t\u00eb Zvicr\u00ebs p\u00ebr vaksin\u00ebn kund\u00ebr koronavirusit t\u00eb ri.<\/p>\n \u201cDo t\u00eb thosha se n\u00eb k\u00ebt\u00eb moment, \u00e7do vaksin\u00eb q\u00eb ka nj\u00eb efektivitet relativisht t\u00eb mir\u00eb, do t\u00eb thot\u00eb 60 apo 70 p\u00ebr qind efektivitet \u2013 duhet t\u00eb p\u00ebrdoret, pasi t\u00eb jet\u00eb verifikuar siguria e saj\u201d, tha ai.\/REL<\/p>\n","protected":false},"excerpt":{"rendered":" LOND\u00cbR – M\u00eb 30 dhjetor, 2020, Britania u b\u00eb shteti i par\u00eb q\u00eb miratoi p\u00ebr p\u00ebrdorim vaksin\u00ebn kund\u00ebr koronavirusit t\u00eb kompanis\u00eb AstraZeneca dhe Universitetit t\u00eb Oxford-it \u2013 duke shtuar edhe nj\u00eb arm\u00eb n\u00eb arsenalin e k\u00ebtij vendi, n\u00eb luft\u00ebn kund\u00ebr pandemis\u00eb, shkruan agjencia e lajmeve Reuters. Megjithat\u00eb, shkenc\u00ebtar\u00ebt \u2013 si dhe rregullator\u00ebt e barnave n\u00eb […]<\/p>\n","protected":false},"author":1,"featured_media":61889,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[3803,5819,5558,5583,5741,5820,2900],"class_list":["post-61888","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-shendetesi","tag-aktuale","tag-astrazeneca","tag-coronavirus","tag-covid19","tag-pandemia","tag-pfizer","tag-vaksina"],"_links":{"self":[{"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/posts\/61888","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/comments?post=61888"}],"version-history":[{"count":1,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/posts\/61888\/revisions"}],"predecessor-version":[{"id":61890,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/posts\/61888\/revisions\/61890"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/media\/61889"}],"wp:attachment":[{"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/media?parent=61888"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/categories?post=61888"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/tags?post=61888"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nKur Britania miratoi p\u00ebr p\u00ebrdorim vaksin\u00ebn e Pfizer\/BioNTech n\u00eb fillim t\u00eb dhjetorit t\u00eb vitit t\u00eb kaluar, kjo b\u00ebri q\u00eb shum\u00eb rregullator\u00eb, p\u00ebrfshir\u00eb ata n\u00eb Shtetet e Bashkuara dhe BE t\u00eb b\u00ebjn\u00eb t\u00eb nj\u00ebjt\u00ebn gj\u00eb.<\/p>\n